Treace Appoints Guy Guglielmino as Chief Commercial Officer

Core Viewpoint - Treace Medical Concepts, Inc. has appointed Guy Guglielmino as Chief Commercial Officer to lead its commercial efforts and drive innovation, product commercialization, and growth in the surgical treatment of bunions and midfoot deformities [1][2]. Company Overview - Treace Medical Concepts is focused on advancing the standard of care for surgical management of bunions and related midfoot deformities, which affect approximately 67 million Americans, with an estimated 1.1 million being annual surgical candidates [5]. - The company has developed the Lapiplasty® 3D Bunion Correction® System, which addresses the root cause of bunions by correcting deformities in all three planes and securing the unstable joint [5]. - Treace has also introduced the Adductoplasty® Midfoot Correction System for surgical correction of midfoot deformities and the SpeedPlate™ Rapid Compression Implants for various bone fusion procedures [5][6]. Leadership Appointment - Guy Guglielmino brings extensive experience in the medical technology industry, having previously served as President of Recovery Sciences at Enovis and held senior marketing roles at other notable companies [2]. - His appointment is expected to enhance Treace's market growth and innovation capabilities, aligning with the company's mission to meet customer needs and establish new market standards [2].